MML Investors Services
AUPH icon

MML Investors Services’s Aurinia Pharmaceuticals AUPH Stock Holding History

MML Investors Services’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$321K Buy
21,641
+5,998
+38% +$87.7K ﹤0.01% 2516
2025
Q4 		$250K Buy
15,643
+1,765
+13% +$25K ﹤0.01% 2748
2025
Q3 		$153K Sell
13,878
-1,428
-9% -$15.6K ﹤0.01% 2790
2025
Q2 		$130K Sell
15,306
-126
-0.8% -$1.01K ﹤0.01% 2723
2025
Q1 		$124K Buy
+15,432
New +$125K ﹤0.01% 2610

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MML Investors Services's AUPH Position: Q1 2026 in Review

MML Investors Services increased its Aurinia Pharmaceuticals (AUPH) stake by 38% in Q1 2026, buying an estimated $87.7K and bringing the position to 21,641 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #2516.

MML Investors Services first reported a position in AUPH in Q1 2025 and has held it in 5 quarters since. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • MML Investors Services held 21,641 shares of Aurinia Pharmaceuticals worth $321K as of Q1 2026.
  • MML Investors Services bought 5,998 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $87.7K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of MML Investors Services's portfolio in Q1 2026, its #2516 holding.
  • MML Investors Services first reported a position in Aurinia Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.